Comparison
46 Xy True Hermaphroditism C2748897 vs 5q22 Deletion Syndrome Cn119543
Clinical comparison between 46 XY True Hermaphroditism and 5q22 Deletion Syndrome CN119543 for differential diagnosis and treatment planning.
46 Xy True Hermaphroditism C2748897
A rare disorder of sex development where individuals have both ovarian and testicular tissue, typically in those with XY chromosomes.
5q22 Deletion Syndrome Cn119543
A chromosomal deletion involving a specific region of chromosome 5, which can affect development, cognition, and various body systems. Treatment depends on the specific symptoms present.
6 comparison axes
Onset
46 Xy True Hermaphroditism C2748897
0-null
5q22 Deletion Syndrome Cn119543
Variable
Onset patterns differ
Severity
46 Xy True Hermaphroditism C2748897
severe
5q22 Deletion Syndrome Cn119543
moderate
Different severity levels
Chronic
46 Xy True Hermaphroditism C2748897
Chronic
5q22 Deletion Syndrome Cn119543
Chronic
Differing course
Communicable
46 Xy True Hermaphroditism C2748897
No
5q22 Deletion Syndrome Cn119543
No
Different transmission
Body System
46 Xy True Hermaphroditism C2748897
reproductive
5q22 Deletion Syndrome Cn119543
congenital
Same/different system
Category
46 Xy True Hermaphroditism C2748897
genetic
5q22 Deletion Syndrome Cn119543
genetic
Different category
Bottom line
46-xy-true-hermaphroditism-C2748897 and 5q22-deletion-syndrome-CN119543 differ in severity
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy True Hermaphroditism C2748897 | 5q22 Deletion Syndrome Cn119543 | Discriminating power |
|---|---|---|---|
| Defining feature | Both ovarian and testicular tissue in a person typically described as 46,XY. | A deletion involving 5q22; effects vary and are not defined by gonadal tissue. | High |
| Development and cognition | Broader developmental or cognitive effects are not established in the source. | Development, cognition, and multiple body systems may be affected. | High |
| Onset | Source onset is listed as 0-null, so timing is not established. | Onset is described as variable. | Moderate |
When to favor each condition
Choose 46 Xy True Hermaphroditism C2748897 when
46,XY karyotype plus documented ovarian and testicular tissue
This directly matches the supplied definition.
High
The principal concern is sex development or reproductive anatomy
The source assigns the reproductive system and severe severity.
Moderate
No 5q22 deletion has been identified
This weakens the right concept, but genetics review is still needed.
Moderate
Choose 5q22 Deletion Syndrome Cn119543 when
Testing confirms a deletion involving 5q22
The chromosomal finding defines the right concept.
High
Variable developmental, cognitive, or multisystem concerns are present
These domains are explicitly named in the source.
Moderate
Mixed ovarian and testicular tissue is absent
That tissue pattern is central to the left concept.
Moderate
How key tests differ
| Test | 46 Xy True Hermaphroditism C2748897 | 5q22 Deletion Syndrome Cn119543 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | Typically XY; this alone does not prove mixed gonadal tissue. | A deletion involving 5q22 may be detected; breakpoints are not supplied. | Genetic results require specialist interpretation and do not replace clinical assessment. |
| Gonadal histology or specialist imaging | Ovarian and testicular tissue is the defining finding. | No defining gonadal result is established by the source. | Tissue findings support the left concept but do not diagnose the deletion. |
| Developmental and system-specific assessment | No specific extra-reproductive test pattern is established. | Evaluation is individualized because affected systems vary. | Abnormal results are findings, not automatic diagnoses. |
Prognosis comparison
46 Xy True Hermaphroditism C2748897
- Outcome
- Long-term outcome is not established from the supplied data.
- Factors
- Gonadal findings, sex-development needs, and follow-up may influence care.
5q22 Deletion Syndrome Cn119543
- Outcome
- Outcome varies with the deletion and the symptoms present.
- Factors
- Developmental, cognitive, and affected-system findings may shape the course.
Time frame: Both are labeled chronic, but precise timelines are not established.
Supplied severity differs, severe versus moderate, yet individual prognosis needs clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Reproductive or endocrine effects | Possible because both gonadal tissues are present; exact risks are not established. Not specifically established from the supplied description. Do not infer infertility, malignancy, or hormone thresholds. |
| Neurodevelopmental effects | Not established by the source. Cognition and development may be affected to a variable degree. Severity must be assessed individually. |
| Multisystem involvement | Source emphasis is reproductive sex development. Various body systems may be involved. No complication rates are supplied. |
Patient education highlights
- HighWhat the terms mean
The left concept involves ovarian and testicular tissue, often discussed as ovotesticular disorder of sex development. The right is a variable 5q22 deletion.
- HighLimits of tests
A karyotype, microarray, or tissue result needs specialist review. An abnormal result is not by itself a complete diagnosis.
- MediumCare planning
Neither condition is communicable. Both are chronic, and management depends on individual findings; no treatment doses are established here.